s1226
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02616770)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- s1226
- s1226
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04949386 | Phase 2 | Sep 30, 2021 | SolAeroMed Inc., University of Calgary |
| NCT04738136 | Phase 2 | Sep 15, 2021 | SolAeroMed Inc., University of Calgary |
| NCT03903913 | Phase 2 | May 31, 2019 | SolAeroMed Inc., University of Calgary |
| NCT02334553 | Phase 2 | Jan 1, 2015 | SolAeroMed Inc., University of Calgary |
| NCT02616770 | Phase 1 | Mar 1, 2014 | Pharma Medica, SolAeroMed Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| SolAeroMed Inc. | For profit | 5 | 5 | 2 | 2014 |
| University of Calgary | Academic/Hospital | 4 | 0 | 1 | 2015 |
| Pharma Medica | For profit | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1